Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 7 of 16
Integrated Intervention Post-Sexual Assault
NCT04724746
taVNS for Upper Limb Rehabilitation
NCT04129242
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
NCT04218123
UH3 Varenicline for Cannabis Use Disorder
NCT03980561
Envarsus Neurotoxicity Burden in Liver Transplant Patients
NCT03823768
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors
NCT03980509
Cannabis and Tobacco Co-use Study
NCT04228965
Hemofilter Life Span, ECLS And/or CRRT
NCT04193865
Yoga Adjunct for Scleroderma
NCT04491396
E-Visit for COPD and Smoking Cessation
NCT04155073
Effect of Epidural Stimulation on Muscle Activation and Sensory Perception
NCT04157400
Monitored Anesthesia Care vs. General Anesthesia for Transcatheter Aortic Valve Replacement
NCT04107038
rTMS to Enhance Cognitive Performance and Promote Resilience
NCT04123496
JUUL vs. Mod E-cigarette Study
NCT04237272
Voice Changes During ECT
NCT04420793
Enhancing School-Based Violence Prevention
NCT04087772
Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC
NCT04098458
E-learning+ Rehab Therapy
NCT04245449
Smartwatch App for Vibration Stimulation
NCT04050917
Neuroplasticity With Daily Use of a Sensorimotor Priming Vibration System to Improve Hand Function After Stroke
NCT04026399
Dotarem Evaluation for Myocardial Perfusion CMR
NCT03937921
Impact of Lofexidine on Stress, Craving and Opioid Use
NCT03718065
Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans
NCT04621500
Single-arm Phase II Study of NDURE for Patients With HNC
NCT03821064
Oxytocin to Enhance Alcohol Behavioral Couple Therapy (ABCT)
NCT03846505
Smoking Cessation E-Visit
NCT04316260
Tobacco Treatment in the Context of Lung Cancer Screening
NCT03927989
Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT03450343
Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns
NCT03844672
The Safety and Efficacy of a SinuSonic Intervention
NCT03906968
Reducing Prescription Opioid Misuse: ROPEs Pilot Trial
NCT03691948
Dermabond PRINEO for Total Shoulder Arthroplasty
NCT03860181
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
NCT03928483
Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer
NCT03677076
N-Acetylcysteine for Adolescent Alcohol Use Disorder
NCT03707951
Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent
NCT03681769
Memory Phenotype and PD-1 Inhibition Response in Oral Cancer
NCT03862066
Activate For Life: mHealth Intervention To Address Pain And Fatigue In Low-income Older Adults Aging In Place
NCT03853148
Post-Stroke Optimization of Walking Using Explosive Resistance
NCT03826771
Fenofibrate in Type 2 Diabetes
NCT03829514
Behavioral Memory Modulation in Nicotine Addiction
NCT03744559
Low Intensity Focused Ultrasound Pulses (LIFUP) to Modulate Pain
NCT04339972
Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH)
NCT03735745
A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection
NCT03748992
Impact of Progesterone on Stress Reactivity and Cannabis Use
NCT03729869
Approach Bias Modification for the Treatment of Cannabis Use Disorder
NCT03629990
Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients
NCT03712371
Trauma Informed Prevention for Substance Use and Risky Sex
NCT03710720
Steroids and Pain Control After Tonsillectomy
NCT03995628
Hollings Cancer Center Varenicline Sampling Study
NCT03742154
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.